openPR Logo
Press release

Drug Delivery Technology Market will Grow at a CAGR of 7.5% Globally by 2021

09-04-2017 12:05 PM CET | Health & Medicine

Press release from: Market Research Engine

Drug Delivery Technology Market

Drug Delivery Technology Market

The drug delivery technology market is segmented on the lines of its route of administration, end user and regional. Based on route of administration segmentation it covers pulmonary drug delivery,ocular drug delivery,topical drug delivery,transmucosal drug delivery, oral drug delivery, injectable drug delivery,nasal drug delivery andimplantable drug delivery. Pulmonary drug delivery is further segmented into nebulizers, dry powder inhaler and metered dose inhaler. Ocular drug delivery segmentation contains ocular devices, semi solid and liquid. Under tropical drug delivery it covers transdermal, solid, semi solid and liquid. Transmucosal drug delivery segmentation covers oral and other. Based on oral drug delivery segmentation it covers liquid, solid and semi solid. Under injectable drug delivery segmentation it contains devices and formulations.

You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/drug-delivery-technology-market

The Drug Delivery Technology Market is expected to exceed more than US$ 1600 Billion by 2021; Growing at a CAGR of 7.5% in the given forecast period.

The report mentions the detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche (Switzerland),Pfizer, Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Novartis AG (Switzerland), and Bayer AG (Germany). Company profile includes details such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.

Table of Contents

1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Regulatory Scenario
7 Drug Delivery Technology Market, By Route of Administration
8 Drug Delivery Technology Market, By Facility of Use
9 Drug Delivery Technology Market, By Region
10 Competitive Landscape
11 Company Profiles
11.1 Introduction
11.2 Johnson & Johnson Services, Inc.
11.3 Novartis AG
11.4 F. Hoffmann-La Roche Ltd.
11.5 Pfizer, Inc.
11.6 Bayer AG
11.7 Antares Pharma, Inc.
11.8 Becton, Dickinson and Company
11.9 Glaxosmithkline PLC
11.10 3M
11.11 Merck & Co., Inc.
11.12 Sanofi

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Technology Market will Grow at a CAGR of 7.5% Globally by 2021 here

News-ID: 696638 • Views: 322

More Releases from Market Research Engine

Automotive Lubricants Market 2020 Growth Opportunities, Revenue, Industry Analys …
New York, January 24, 2020: The automotive lubricants market is expected to exceed more than 598 million Gallons by 2024; Growing at a CAGR of more than 8% in the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BP plc, Chevron Corporation, ExxonMobil Corporation, ConocoPhillips Corporation, Fuchs
Contrast Media Injectors Market is expected to grow more than US$ 1.77 Billion B …
Market Research Engine has recently revealed their new study on how the market of contrast media injectors is blooming because of high demand for imaging products like MRI scans and CT scans. The report focuses mainly on the Global market for contrast media injectors, driving factors that lead to higher market share and restraining factors that restrain the growth. The report is titled - Contrast Media Injectors Market By Product
Global Tuberculosis Testing Market will Reach US$ 2600 Million by 2020
Tuberculosis tests are existing to diagnosis tuberculosis. These tests are used to discover tuberculosis bacteria which are subjected to tuberculosis drug resistant or TB drug treatment. Tuberculosis test are used to determine if someone has infected with tuberculosis bacteria. The expansion of tuberculosis disease is occurring in two stages. In first stage a person contains TB bacteria that are latent TB. In second stage the TB bacteria will reproduced adequately
Point-Of-Sale (POS) Terminals Market is Expected to Grow At CAGR Of 14% by 2023
This report is to help buyers of point of sale terminals. Point of sale terminals are hardware and software systems used to execute and manage retail transactions. POS terminals have wide range of applications which includes payments, inventory management, printing bills and carrying out loyalty programs across various end-use verticals such as retail, hospitality and entertainment. A point of sale terminal may include a cash register, a computer, a receipt

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning